Celgene's Chopra joins e-Therapeutics board
This article was originally published in Scrip
Executive Summary
Biotech company e-Therapeutics has appointed Dr Rajesh Chopra to its board as a non-executive director. Since 2009, Dr Chopra has been vice-president of translational and early drug development at Celgene. Prior to this current role, he spent five years at AstraZeneca in a number of positions including medical science director.